Osteoporosis drugs on every 2026 Minnesota Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Minnesota cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
11 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$4.70/moS5884-145 | AARP Medicare Rx Saver from UHC$5.30/moS5921-370 | Wellcare Value Script$9.60/moS4802-158 | Wellcare Classic$12.70/moS4802-089 | Humana Value Rx Plan$20.80/moS5884-204 | SilverScript Choice$29.70/moS5601-050 | HealthSpring Extra Rx$66.50/moS5617-375 | MedicareBlue Rx Standard$101.00/moS5743-001 | Humana Premier Rx Plan$103.70/moS5884-171 | HealthSpring Assurance Rx$125.90/moS5617-123 | AARP Medicare Rx Preferred from UHC$140.20/moS5921-406 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 2$1.00QL 30/30d | Tier 2$7.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$2.00 | Tier 1$0.00 | Tier 1$0.00QL 120/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$5.00QL 30/30d |
| risedronategeneric Actonel | Not covered | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Tier 1$2.00QL 1/28d | Not covered | Not covered | Not covered | Not covered | Not covered |
| ibandronategeneric Boniva | Tier 325%QL 1/28d | Tier 317%QL 1/28d | Tier 2$3.00QL 1/30d | Tier 325%QL 1/30d | Tier 320%QL 1/28d | Tier 1$2.00QL 1/30d | Tier 317%QL 1/28d | Tier 2$1.00QL 1/28d | Tier 3$45.00QL 1/28d | Tier 321%QL 1/28d | Tier 318%QL 1/28d |
| Proliadenosumab | Tier 434%QL 1/180d | Not covered | Not covered | Not covered | Tier 434%QL 1/180d | Not covered | Tier 431%QL 1/180d | Not covered | Tier 450%QL 1/180d | Tier 430%QL 1/180d | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Tier 435%QL 1/180d | Tier 440%QL 1/180d | Tier 427%QL 1/180d | Not covered | Tier 435%QL 1/180d | Not covered | Tier 4PA42% | Not covered | Not covered | Tier 434%QL 1/180d |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Tier 5PA25%QL 2.24/28d | Not covered | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Not covered | Not covered | Not covered | Tier 5PA33%QL 2.24/28d | Not covered | Not covered |
| teriparatidegeneric Forteo | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25% | Tier 5PA25%QL 2.48/28d | Not covered | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA31%QL 2.48/28d |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Not covered | Tier 5PA25% | Not covered | Not covered | Tier 5PA31%QL 1.56/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.